Bookmark and Share

Compound Summary for: CID 26757


Also known as: Emsam; L-Deprenalin; Jumex; Eldepryl; Carbex; L-Deprenyl; Zelapar; Selegilinum; Selegilina
Molecular Formula: C13H17N   Molecular Weight: 187.28078   InChIKey: MEZLKOACVSPNER-GFCCVEGCSA-N
A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.   From: MeSH
Show subcontent titlesTable of Contents
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Biomedical Effects and Toxicity
Safety and Handling
Exposure Standards and Regulations
Monitoring and Analysis Methods
Biomolecular Interactions and Pathways
Biological Test Results
Chemical and Physical Properties
_ _